baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

JP Morgan Call 120 R66 17.01.2025/ DE000JL2CUR9 /

2024-06-21 10:37:33 AM	Chg.+0.11	Bid10:00:42 PM	Ask10:00:42 PM	Underlying	Strike price	Expiration date	Option type
2.62EUR	+4.38%	- Bid Size: -	- Ask Size: -	PHILLIPS 66 D...	120.00 -	2025-01-17	Call

GlobeNewswire 06-21 Lifetime Brands, Inc. Announces Results of 2024 Annual Meeting

GlobeNewswire 06-20 The International Food Information Council (IFIC) Releases Annual Food & Health Survey Revealing Ris...

GlobeNewswire 06-18 EyePoint Pharmaceuticals to Host R&D Day on June 26, 2024

GlobeNewswire 06-17 Phillips Edison & Company Inc. Invites You to Join Its Second Quarter 2024 Earnings Conference Call

GlobeNewswire 06-17 EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

GlobeNewswire 06-13 Rygen Technologies Launches Next-Gen Supply Chain Solution: AI-enabled TMS

GlobeNewswire 06-13 FibroBiologics Set to Join Russell 2000® Index

GlobeNewswire 06-12 Greystone Closes $22.9 Million in Total Debt Placement and Preferred Equity Financing for Fort Worth...

GlobeNewswire 06-06 FibroBiologics to Present at Extracellular Matrix Pharmacology Congress 2024

GlobeNewswire 06-05 EyePoint Pharmaceuticals to Present at Goldman Sachs 45th Annual Global Healthcare Conference

GlobeNewswire 05-30 Celebrate Life’s Sweet Surprises in New Children’s Book THE ICE CREAM TREE

GlobeNewswire 05-29 Phillips Edison & Company to Present at Nareit REITweek 2024 Investor Conference

GlobeNewswire 05-22 Entero Therapeutics to Present Corporate Update at 2024 BIO International Convention

GlobeNewswire 05-20 Entero Therapeutics Presents Two Posters on Celiac Disease Research at the 2024 Digestive Disease We...

GlobeNewswire 05-16 Optimal Daily Dairy Consumption Remains Elusive Despite Well-Established Health Benefits

GlobeNewswire 05-16 First Wave BioPharma Changes Name to Entero Therapeutics

GlobeNewswire 05-16 EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

GlobeNewswire 05-15 FibroBiologics Announces 2024 Annual Meeting of Stockholders

Newsfile Corp 05-15 King Fuels Announces Strategic Expansion of Its Fuel Distribution Network in Texas, Colorado, Kansas...

GlobeNewswire 05-14 FibroBiologics Files 2024 First Quarter Report

GlobeNewswire 05-14 Kontrolmatik Technologies and Pomega Standardize Operations With Siemens Solutions and Form an Engin...

GlobeNewswire 05-13 Safe Boating Campaign’s Annual National Safe Boating Week Celebrates All Boaters This May 18-24, 202...

GlobeNewswire 05-10 First Wave BioPharma, Inc. to raise approximately $1.1 million of Gross Proceeds Priced At-the-Marke...

GlobeNewswire 05-09 First Wave BioPharma and Celiac Journey to Host Nasdaq Event in Support of Celiac Disease Awareness ...

GlobeNewswire 05-08 Phillips Edison & Company Announces Pricing of Offering of $350 Million Aggregate Principal Amount o...

JP Morgan Call 120 R66 17.01.2025/ DE000JL2CUR9 /

If you wish to receive reply to your feedback, please provide your email address.